2017
DOI: 10.1245/s10434-017-5965-5
|View full text |Cite
|
Sign up to set email alerts
|

Oncologic Outcomes After Treatment for MRI Occult Breast Cancer (pT0N+)

Abstract: Background Studies assessing outcomes in occult breast cancer have often included women treated before the routine use of MRI. We undertook to examine outcomes in patients presenting with axillary adenopathy and no primary detectable on MRI or other imaging modalities. Methods All patients with axillary nodal metastases consistent with breast carcinoma, and no detectable breast primary on physical exam, mammography, or MRI treated between 1/1/1996 and 6/30/2011 were identified from an institutional database.… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
28
0

Year Published

2019
2019
2024
2024

Publication Types

Select...
5
3

Relationship

0
8

Authors

Journals

citations
Cited by 27 publications
(29 citation statements)
references
References 32 publications
0
28
0
Order By: Relevance
“…Because therapy may reduce enhancement in breast lesions, during and after chemotherapy, evaluation of late phase enhancement may still be important. negative, radiation therapy to the ipsilateral breast is as safe as mastectomy, and therefore MRI in this setting may prevent unnecessary mastectomies (154,155).…”
mentioning
confidence: 99%
“…Because therapy may reduce enhancement in breast lesions, during and after chemotherapy, evaluation of late phase enhancement may still be important. negative, radiation therapy to the ipsilateral breast is as safe as mastectomy, and therefore MRI in this setting may prevent unnecessary mastectomies (154,155).…”
mentioning
confidence: 99%
“…Breast MRI has only recently become increasingly utilized as a routine tool in diagnosing OBC. A recent study showed favorable prognosis in MRI-OBC patients after BCT [ 14 ], with 4 recurrences among 25 patients (2 in the breast and 2 in distant organs), and a 5-year DFS of approximately 80%. We also found a favorable outcome after BCT in this study.…”
Section: Discussionmentioning
confidence: 99%
“…[ 13 ] Single institution 36 2000–2011 91.7% ALND (91.7%), TM (25.0%), no breast surgery (75.0%) Breast (91.7%), RNI (77.8%) 0.0% 5-yr OS 100.0% N1 (77.8%), N2 (16.7%), N3 (5.6%) McCartan et al. [ 14 ] Single institution 38 1996–2011 100.0% ALND + WBRT (65.8%) ALND + TM (34.2%) Breast (100%), RNI (55.3%), chest wall (46.2%) 8% (only in WBRT group) 77.0% for TM, 10-yr DFS 67.0% for WBRT N1 (57.9%), N2 (31.6%), N3 (10.5%) The present study Multicenter 66 2001–2013 100.0% ALND + BCT (100.0%) Breast (18.2%), Breast + RNI (75.7%), RNI (6.1%) 9.1% 92.1% at 5-yrs, DFS 80.6% at 10-yrs Included 12 patients with SCN or IMN metastasis Abbreviation: MRI, magnetic resonance imaging; RT, radiotherapy; ALND, axillary lymph node dissection; TM, total mastectomy NR, not reported; LR, locoregional; NCDB, the National Cancer Database of the United States; OS, overall survival; SEER, the Surveillance, Epidemiology and End Results Program; BCS, breast-conserving surgery; RNI, regional lymph node irradiation; DFS, disease-free survival; SCN, supraclavicular lymph nodes. a years of patient’s accrual or periods of study inclusion.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…The only review of pOBC patients comparing mastectomy to whole breast RT (WBRT) has been performed at Memorial Sloan Kettering Cancer Center (MSKCC) by McCartan et al. (2017) [ 39 ]. Thirty-eight patients were treated as per current National Comprehensive Cancer Network (NCCN) guidelines with either ALND and WBRT (n = 25) or ALND and mastectomy (n = 13).…”
Section: Diagnostic Techniques and Their Effect On The Incidence And mentioning
confidence: 99%